Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivess... (nctional class at one year number of ant...)

HOME >> MEDICINE >> TECHNOLOGY

Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease

Date:10/22/2007

nctional class at one year, number of anti-anginal drugs after one year, overall MACE rate at one month post-procedure and at six months, two, three and five years.

"With drug-eluting stents (DES) and lower restenosis rates, interventional cardiologists are performing PCI more often in patients with increasingly complex CAD, including multivessel disease," said Dr. De Bruyne. "Furthermore, some physicians are stenting all intermediate lesions with DES regardless of the physiologic significance of those lesions. DES are expensive and have been associated with potential late complications. Therefore, the objective of FAME is to help us identify an approach to PCI that will improve overall clinical outcomes and reduce healthcare expenditure."

In addition to Dr. De Bruyne, the FAME study's investigators are represented by Nico H. J. Pijls, M.D., Ph.D.; Pim Tonino, M.D.; Uwe Siebert, M.D., M.Sc., M.P.H., Sc.D.; and William Fearon, M.D. A paper outlining the rationale and design of the trial is published in the October issue of American Heart Journal (American Heart Journal Vol.154, No. 4, pp.632-636). For more information about the FAME study, visit http://clinicaltrials.gov/ct/gui/show/NCT00267774?order=17 .

Media Contacts:

David Schull or Benjamin Carmichael

Russo Partners

+1 212-845-4271

+1 858-717-2310 (during TCT 2007)

david.schull@russopartnersllc.com

benjamin.carmichael@russopartnersllc.com

SOURCE Radi Medical Systems AB
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine technology :

1. Monitoring Patient Glucose Levels: New Advances in software make it easier
2. Managing Preanalytical Processes for Patient Safety
3. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
4. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
5. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:

(Date:11/25/2009)...,, HARBIN,China,Nov.25/PRNewswire-Asia-FirstC..."or"theCompany")(Nasdaq: CSKI ),a,leadingfullyinte...over-the-counterdrugsinthePeople,sRepublicofChina(...theChineseNationalInstitutefor,theControlofPharmac...ortwoofitsnewproducts:itsDiagnosticKitforHumanPros...

(Date:11/25/2009)...,, WALTHAM,Mass.,Nov.25/PRNewswire/--Accordin...onmedicaltechnologymarketintelligence,thenearly$3b...toseerapidgrowthoverthenextfiveyearsdespitetherece... 2010 reportfindsthatthismarketwillremainhighlydy...ngspecializeddevicesinpreviouslyunderservedsegment...

(Date:11/25/2009)...,, DELFT,TheNetherlandsandJOHANNESBURG,Novemb...ivisionandPyxisDiscoveryannouncedtoday,thattheyhav...companies,services. , Pyxis,sworldclasscomput...upledwithiThemba,sservicedivisiontoprovidemedicina...throughPyxis,internationalclientnetwork.iThembaPh...

Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2 China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3 US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2 US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3 iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2 Consciousness Helps the Mind and Body Work Together 58773 1 Consciousness Helps the Mind and Body Work Together 58773 2 Long Term Care Consumer Voices Strengthened 58768 1 Long Term Care Consumer Voices Strengthened 58768 2 Yongye International Announces 2010 2012 Strategic Plan 14335 1 Yongye International Announces 2010 2012 Strategic Plan 14335 2 Yongye International Announces 2010 2012 Strategic Plan 14335 3 Yongye International Announces 2010 2012 Strategic Plan 14335 4 Yongye International Announces 2010 2012 Strategic Plan 14335 5

[0] China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits [0] US Trauma Fixation Device Market Not Seeing Signs of Slowdown [0] iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering

...R, Mich., March 6 NanoBio(R) Corporation has,rece...ng from Perseus LLC,after having successfully met ...the efficacy and safety of its two topical treatme...ngth of its influenza vaccine in,ferret studies., ...chigan, has received a,total of $30 million over t...

...ive Hemoglobin Receives Rave Reviews from Attendee... Exhibit, IRVINE, Calif., March 6 Masimo, the in...h Motion and Low Perfusion pulse,oximetry, reporte...,accuracy and clinical effectiveness of the Masimo...s week to over 8,000 anesthesiologists at the 14th...

Other Medicine Technology:NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones 2 New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 2 New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 3 New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 4 New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 5 New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care 6

NanoBio(R) Corporation Completes $30 Million in Equity Funding by Meeting Key Development Milestones New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care

(Date:11/26/2009)... Research Triangle Dental (RTD... North Carolina, today announced the expansion of ...UMINEER Dentist, Dr. Doug Macmillan. , ...iangle Dental is pleased to announce that Dr. Doug...cently completed an additional advanced training s...

(Date:11/25/2009)..., KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBartleHal...argestmedicalcliniconDec.9-10,whenKansasCityhostst...eople. ,, "Thisfreecliniceventhasthepotentialto...nsteadofjustoneandbeheldonweekdaysinsteadofoverawe...reeHealthClinicandpresidentoftheNationalAssociatio...

(Date:11/25/2009)..., LONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivi...dseniorsinthegreaterLongBeachareathankstoFaithInAc...ependenceatHome(IAH),adivisionofSCANHealthPlan.For...edsofvolunteerstodeliverwarmThanksgivingmealstosen...,SouthLosAngelesandsurroundingcities. ,, "Ourwa...

(Date:11/25/2009)..., BroadPoliticalEndorsements,Business,andPressJo...wswire-USNewswire/--Onceagain,theNationalBipolarFo...tionendorsingtheir"Safe,tilStable"program,whichisn...eforbipolardisorder.Today,theNationalBipolarFounda...pressPriorityMailfromtheLt.GovernorofLouisianaMitc...

(Date:11/25/2009)...s stress increase blood pressure? This simple que...any years. New Stress-related gene Modulates High...se blood pressure? This simple question has been ... new research has for the first time established a...od pressure response to stress in mice as well as ...

Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2 Health News:Kansas City Prepares for Largest Free Health Clinic 2 Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3 Health News:New stress-related gene modulates high blood pressure in mice and men 2

[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental [1] Kansas City Prepares for Largest Free Health Clinic [0] SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors [0] First Time-Door is Open for Family Discussion of Bipolar Disorder [1] New stress-related gene modulates high blood pressure in mice and men

...2009 The AMERIGROUP Foundation today announced th...ounder of Healthy Kids, Smart Kids, by designating... demonstrated innovation and leadership as an advo... energize organizations to help members and employ...

...rnings per Share of 9 cents and Non-GAAP Earnings ...ripts-Misys Healthcare Solutions, Inc. (Allscripts...ree and nine months ended February 28, 2009. , ,...ults of Allscripts for the complete fiscal quarter...

...l 2 enlyten is pleased to announce the signing of... Shaquille O,Neal as the official enlyten spokespe...ative of the enlyten brand. He is indisputably one...dge to everything he does. And a ,competitive edge...

...acking this factor failed to develop common sympto...althDay News) -- A gene on the X chromosome appear...n are much more likely to develop the disease than... the gene did not develop common disease symptoms ...

... 2009 Researchers at UT Southwestern Medical Cent...amine helps brain cells process important informat...s that this neurotransmitter, one of the molecules...mportant information differently than mundane info...

...aling Our World: Leveraging Innovation, Social Ent... 8:30 a.m. to 1:30 p.m. , , Forum Highlights: ...and White House Special Advisor for Green Jobs, En...nd Van Jones Q&A , , WALTHAM, Mass., April 2...

Dr. Yvonne Sanders-Butler of Atlanta Honored as 'Healthy Hero' By the AMERIGROUP Foundation Allscripts Reports Fiscal 2009 Third Quarter Results enlyten Signs Shaquille O'Neal as Official Spokesperson Gene May Explain Women's Heightened Lupus Risk UT Southwestern researchers reveal how the brain processes important information Bentley University Presents Fifth Annual Bentley Leadership Forum, in Cooperation With TIME

Optium DBM Putty, TPUT05

I/C Graft Chamber, GDS010

Demineralized Cortical Powder, DGC20

...NT image guidance system offers the Zone, a graphi...llimetric accuracy has been established in nonclin... numerical value. It is simple to set up, intutive...ze-frame navigation and comes with the touchpad fo...

Medicine Products:

Optium DBM Putty, TPUT05 I/C Graft Chamber, GDS010 Demineralized Cortical Powder, DGC20 Landmarx ENT Image Guidance System

Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivess...(nctional class at one year number of ant...),Health